Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

Leuk Lymphoma. 2015 Feb;56(2):548-9. doi: 10.3109/10428194.2014.939971. Epub 2014 Oct 7.

Authors

Barbara Kiesewetter¹, Markus Raderer

Affiliation

¹ Division of Oncology, Department of Internal Medicine I, Medical University Vienna , Vienna , Austria.

PMID: 25120052
DOI: 10.3109/10428194.2014.939971

No abstract available

Publication types

Letter
Comment

MeSH terms

Autoimmune Diseases / complications*
Humans
Immunologic Factors / therapeutic use*
Male
Multiple Myeloma / complications*
Multiple Myeloma / drug therapy*
Thalidomide / analogs & derivatives*

Substances

Immunologic Factors
Thalidomide